These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5650706)

  • 21. [Action of sparteine on cardiac output: radiocardiographic research].
    Modica G; Musco A; Cascone O; Amaro A
    Boll Soc Ital Cardiol; 1966; 11(4):1093-9. PubMed ID: 5992022
    [No Abstract]   [Full Text] [Related]  

  • 22. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low doses of inhaled nitric oxide in heart transplant recipients.
    Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
    J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of bradykinin on total peripheral resistance and regional vascular resistance in the rat.
    Arcidiacono FG; Reininger EJ; Sapirstein LA
    Bibl Anat; 1967; 9():29-32. PubMed ID: 6029880
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methodology of hemodynamic study of a vasodilator drug (author's transl)].
    Morgant C; Merillon JP; Motte G; Guiomard A; Gourgon R
    Anesth Analg (Paris); 1980; 37(9-10):561-6. PubMed ID: 7469072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of dopexamine HCl in conscious and halothane-anaesthetised horses.
    Muir WW
    Equine Vet J Suppl; 1992 Feb; (11):24-9. PubMed ID: 9109955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged infusion of varied doses of dopexamine hydrochloride for circulatory failure after cardiac surgery.
    Santman FW; Thomas SM; Hoskins B
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):13. PubMed ID: 2577706
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term use of vasodilator agents].
    Luomanmaki K; Frick MH
    Duodecim; 1982; 98(2):139-49. PubMed ID: 7060511
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodynamic effect of sublingual nifedipine in patients with congestive heart failure.
    Wasir HS; Sood AK
    Indian Heart J; 1984; 36(1):8-14. PubMed ID: 6706374
    [No Abstract]   [Full Text] [Related]  

  • 31. [Guanethidine and thyrotoxicosis. Influence of prolonged treatment on hemodynamic indexes].
    Botti G; Tagliavini S; Portioli I; Castello S; Rocchi F
    Folia Cardiol; 1968; 27(4):175-86. PubMed ID: 5756272
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemodynamic effects of experimental hypercitremia.
    Corbascio AN; Smith NT
    Anesthesiology; 1967; 28(3):510-6. PubMed ID: 6023523
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
    Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
    Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R; Bender F; Gülker H; Specker E; Molinski M
    Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic effects of contrast media. I. Response in normal subjects].
    Chioin R; Scognamiglio R; Stritoni P; Razzolini R; Congedo E; Corbara F; Boffa GM; Fusaro A
    G Clin Med; 1980 Oct; 61(10):759-68. PubMed ID: 7239051
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the cardiovascular effects of synthetic vasopressin.
    Nakano J
    J Pharmacol Exp Ther; 1967 Jul; 157(1):19-31. PubMed ID: 6029485
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of intravenous Mg++ solutions on renal excretion of potassium, sodium, calcium, chloride, intraleukocytic potassium and peripheral vascular resistance: a metabolic and hemodynamic study in normal volunteers.
    Glänzer K; Schlebusch H; Sorger M; Pannenbecker D; Krück F
    Magnesium; 1984; 3(4-6):324-38. PubMed ID: 6536840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of the new vasodilator drug Bay k 5552 in man.
    Vogt A; Neuhaus KL; Kreuzer H
    Arzneimittelforschung; 1980; 30(12):2162-4. PubMed ID: 7194078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic studies with the p-hydroxyphenyl derivative of orciprenaline].
    Lichtlen P; Stutz R
    Arzneimittelforschung; 1969 Feb; 19(2):147-9. PubMed ID: 5818751
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of the automated management of hypertension after open heart surgery. The relevance of the initial systemic vascular resistance as index for predicting hemodynamic response to computer-controlled nitroprusside infusion.
    Pomer S; Elert O; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):207-13. PubMed ID: 6715091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.